Scientists
have outlined a method which enables the rapid isolation and concentration of
infectious bacteria from complex clinical samples to help speed up bacterial
identification.
FcMBL
is a recombinant form of the human blood protein, Mannose Binding Lectin (MBL),
fused to a portion of the antibody Fc domain. The engineered protein can bind
to more than 90 different microbial pathogens and toxins, ranging from fungi to
bacteria, viruses and parasites and it even binds antibiotic-resistant
organisms.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources